G. Quéreux

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

Induction of toll-like receptors by Propionibacterium acnes

S. Jugeau, Isabelle Tenaud, Anne‐Chantal Knol et al. · British Journal of Dermatology · 2005 · 320 citations

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

John M. Kirkwood, Michele Del Vecchio, Jeffrey S. Weber et al. · Nature Medicine · 2023 · 174 citations · Full text

Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France

Florent Grange, P. Joly, Coralie Barbe et al. · JAMA Dermatology · 2014 · 103 citations

Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome

G. Quéreux, Sónia M Ribeiro Marques, Jean‐Michel Nguyen et al. · Archives of Dermatology · 2008 · 102 citations